Ottawa Mariott, Ottawa, Canada
Nov 1 2011 7:00AM - Nov 2 2011 3:00PM
CALL FOR ABSTRACTS ALL ABSTRACTS ARE DUE BY MAY 16, 2011 ABSTRACT AUTHORS NOTIFIED BY JUNE 10, 2011 Please submit all poster abstracts using the online form at: http://www.diahome.org/DIAHOME/GetInvolved/AbstractSelectAMeeting.aspx All abstracts must be received by May 16, 2011. Abstracts will be reviewed and authors will be notified of results by June 10, 2011. PROGRAM OVERVIEW The biopharmaceutical community continues to experience paradigm shifts in drug development. Further global changes occur with respect to drug development and regulatory oversight and traditional and non-traditional partnerships in healthcare. Several factors influencing these changes include: new scientific approaches; biomarkers and individualized medicines; health care reform; technological advances; and the interplay between safety pharmacovigilence and effectiveness research. In order to remain competitive, Canada will need to foster innovation in these areas to facilitate market access to medicines. The rapid pace of change will create new opportunities and challenges to our current ways of thinking and operating. This program will highlight information on changes occurring to drug development models, regulatory oversight frameworks and new emerging opportunities and challenges with traditional and non-traditional partnerships in healthcare. TUTORIAL Monday, October 31, 2011 — Preregistration required.
|
|
Registration:
|
|
EVENT INFORMATION Contact Joanne Wallace, Program Manager, Phone +1.215.442.6180 Fax +1.215.293.5931, email Joanne Wallace@diahome.org
EXHIBIT INFORMATION Attendees may visit the exhibits during the event and receptions. Contact Jeff Korn, Exhibits Associate, Phone +1.215.442.6184 Fax +1.215.293.5924, email Jeff.Korn@diahome.org
|
|